Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

Vpr Polyclonal antibody

Vpr Polyclonal Antibody for ELISA

Host / Isotype

Rabbit / IgG

Reactivity

immunodeficiency virus 1 and More (2)

Applications

WB, ELISA

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for Vpr in ?

Product Information

51143-1-AP targets Vpr in WB, ELISA applications and shows reactivity with immunodeficiency virus 1 samples.

Tested Reactivity immunodeficiency virus 1
Cited Reactivityhuman, virus
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag0718

Product name: Recombinant Vpr protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-96 aa of NP_057852

Sequence: MEQAPEDQGPQREPHNEWTLELLEELKNEAVRHFPRIWLHGLGQHIYETYGDTWAGVEAIIRILQQLLFIHFRIGCRHSRIGVTRQRRARNGASR

Predict reactive species
Full Name Vpr
Calculated Molecular Weight 11 kDa
GenBank Accession NumberNP_057852
Gene Symbol
Gene ID (NCBI)
RRIDAB_10695191
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

This antibody recognize the VPR gene of Human immunodeficiency virus 1.

Publications

What published studies show

The Vpr Polyclonal antibody (catalog 51143-1-AP) has 17 total citations. It is published across leading journals including Nature Communications, PNAS, Cell Reports, PLoS Biology, mBio, PLoS Pathogens, iScience, Journal of Virology, Retrovirology, Journal of Biological Chemistry, AIDS, and bioRxiv. The research fields covered center on HIV-1 virology, including Vpr-mediated host protein degradation, epigenetic remodeling, DNA damage response and NF-κB signaling, latent infection reactivation, viral integration/replication, and host restriction factor mechanisms (e.g., APOBEC3G, IRF3, RIG-I). Most applications use Western blotting of human cell samples.

SpeciesApplicationTitle
humanWB

Nat Commun

HIV reprograms host m 6 Am RNA methylome by viral Vpr protein-mediated degradation of PCIF1

Authors - Qiong Zhang
humanWB

Proc Natl Acad Sci U S A

CHAF1A/B mediate silencing of unintegrated HIV-1 DNAs early in infection.

Authors - Franziska K Geis
wb

Cell Rep

Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection.

Authors - Edward J D Greenwood
WB

PLoS Biol

DNA damage induced by HIV-1 Vpr triggers epigenetic remodeling and transcriptional programs to enhance virus transcription and latency reactivation.

Authors - Nicholas Saladino
human

mBio

Reversal of Epigenetic Silencing Allows Robust HIV-1 Replication in the Absence of Integrase Function.

Authors - Ishak D Irwan
humanWB

mBio

HIV-1 Vpr-induced DNA damage activates NF-κB through ATM-NEMO independent of cell cycle arrest

Authors - Carina Sandoval
Loading...
||
New chat

Able®

正在加载,请稍候...